TBIOM

AIRMONY is a revolutionary CPAP device designed for treating sleep apnea. It is portable, small, light, autonomous, and equipped with multiple sensors and patented features. Unlike conventional CPAPs, AIRMONY is tubeless, making it more practical and easy to use.

The advanced design of AIRMONY incorporates electronics, software, and blower technology to meet the unique needs of users requiring efficient, autonomous, mobile, and noise-free treatment. It is washable, requires minimal maintenance, and features multiple sensors capturing key patient parameters, including temperature, breath frequency, ECG registration, and head position.

Protected by patented technology in Europe, the United States, and China, AIRMONY eliminates the corrugated tube, allowing for closer proximity sensors and transforming the CPAP into a personal health monitor. The blade design enables consistent airflow and negative dynamic response without the need to invert spin direction. Additional innovative solutions will be protected by three new patents in 2018.

Founded in 2015 and headquartered in Spain, TBIOM received a £221.66K Equity Crowdfunding investment on 01 September 2018. With AIRMONY, users can take control of their sleep apnea treatment, experiencing a better quality of life with a small, lightweight, and completely portable device.